Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
An update from AFT Pharmaceuticals Ltd. ( (AU:AFP) ) is now available.
AFT Pharmaceuticals has announced it will release its full-year FY2025 results on May 22, 2025. The release will be followed by a management presentation via webinar, with materials available on the company’s website and stock exchange platforms. This announcement is significant for stakeholders as it provides insights into the company’s financial performance and strategic direction, potentially impacting its market positioning and investor relations.
More about AFT Pharmaceuticals Ltd.
AFT Pharmaceuticals is a New Zealand-based multinational pharmaceutical company that develops, markets, and distributes a wide range of pharmaceutical products across various therapeutic categories. The company operates in major pharmaceutical distribution channels, including over the counter, prescription, and hospital, with a product portfolio that includes proprietary, in-licensed, patented, branded, and generic drugs. AFT Pharmaceuticals focuses on markets in Australia, New Zealand, Singapore, Malaysia, Hong Kong, USA, Canada, EU excluding Ireland and UK, and licenses its products to over 125 countries worldwide.
YTD Price Performance: -8.63%
Average Trading Volume: 1,780
Technical Sentiment Signal: Buy
Current Market Cap: A$257.9M
For an in-depth examination of AFP stock, go to TipRanks’ Stock Analysis page.